Stocks Comparison
Baxter International vs Boston Scientific: revenue, profit, margins and growth compared
Baxter International brought in $11.2B of revenue in fiscal 2025, Boston Scientific $20.1B in fiscal 2025. Revenue changed by +5.7% at Baxter International and +19.9% at Boston Scientific on the year before, so Boston Scientific grew faster. Baxter International kept -8.5% of its revenue as net profit, Boston Scientific 14.4%. Free cash flow was $332M at Baxter International and $3.7B at Boston Scientific.
Side by side, latest fiscal year
| BAX | BSX | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $11.2B | $20.1B |
| Revenue growth | +5.7% | +19.9% |
| Net income | -$957M | $2.9B |
| Net margin | -8.5% | 14.4% |
| Free cash flow | $332M | $3.7B |
| Free cash flow margin | 3.0% | 18.2% |
| Earnings per share (diluted) | -$1.87 | $1.94 |
| Cash | $2B | $2B |
| Debt | $9.4B | $11.1B |
| Price to earnings | n/a | 22.6 |
| Market value | $12.1B | $63.7B |
| Dividend yield | 2.23% | n/a |
| Rank by revenue in sector | #42 of 523 · Health care | #30 of 523 · Health care |
Over the years
Questions about Baxter International and Boston Scientific
Which is bigger by revenue, Baxter International or Boston Scientific?
Boston Scientific is bigger by revenue: $20.1B in fiscal 2025, against $11.2B for Baxter International in fiscal 2025.
Which keeps more of its revenue as profit, Baxter International or Boston Scientific?
Baxter International had a net margin of -8.5% in fiscal 2025; Boston Scientific had 14.4% in fiscal 2025.
Which grew revenue faster, Baxter International or Boston Scientific?
In their latest fiscal years revenue changed by +5.7% at Baxter International and +19.9% at Boston Scientific.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.